Student Research Symposium Program Portal: Submission #154
Submission information
Submission Number: 154
Submission ID: 9002
Submission UUID: 7bb656e0-4dd9-4252-a550-e5314b473340
Submission URI: /student-research/symposium/research-symposium-program-portal
Submission Update: /student-research/symposium/research-symposium-program-portal?token=Fr-UJOs8WLgcB80XuQXghdclvPA2s4E2Y3l4pS9dq6Q
Created: Mon, 01/19/2026 - 09:30 AM
Completed: Mon, 01/19/2026 - 10:23 AM
Changed: Sun, 02/01/2026 - 09:09 AM
Remote IP address: 67.235.200.51
Submitted by: Anonymous
Language: English
Is draft: No
Webform: Research Symposium Program Portal WF
Submitted to: Student Research Symposium Program Portal
serial: '154'
sid: '9002'
uuid: 7bb656e0-4dd9-4252-a550-e5314b473340
uri: /student-research/symposium/research-symposium-program-portal
created: '1768833018'
completed: '1768836180'
changed: '1769954949'
in_draft: '0'
current_page: ''
remote_addr: 67.235.200.51
uid: '0'
langcode: en
webform_id: research_portal
entity_type: node
entity_id: '14501'
locked: '0'
sticky: '0'
notes: ''
metatag: meta
data:
abstract: |-
Dexmedetomidine is an α₂-adrenergic agonist used widely in anesthesia for its analgesic,
sympatholytic, and recovery-enhancing properties. Despite its benefits, considerable variation
exists in provider dosing practices, limiting consistency in patient outcomes. Current evidence
suggests that ideal body weight (IBW)–based bolus dosing provides a more standardized and
clinically effective approach, improving postoperative pain control, decreasing postoperative
nausea and vomiting (PONV), and reducing delirium in laparoscopic surgical populations.
This project was guided by the PICO question: Do patients undergoing elective
laparoscopic procedures who receive IBW-based bolus doses of dexmedetomidine, compared
with prior non-standardized dosing practices, have better recovery experiences?
Using a pre–post survey design, this practice improvement project evaluated anesthesia
providers’ knowledge, attitudes, and dosing methods before and after viewing an educational
flyer on IBW-based dexmedetomidine dosing. Anesthesia providers at four hospitals were invited
to participate voluntarily. Survey responses demonstrated an increased likelihood of using IBW-
based dosing, greater recognition of key benefits, and a reduction in perceived barriers to
dexmedetomidine use.
additional_research_mentor: 'Dr. Stacey VanDyke, Dr. Jerry Hogan'
annual_description: '5th annual Undergraduate Research Symposium, April 17, 2025'
co_presenters: 'James Sparks'
first_name: Garrett
i_will_be_printing_my_poster: '0'
keywords: 'Cade Garrett Dex'
last_name: Verkaik
major: DNAP
poster_pdf: ''
poster_session_number: ''
poster_thumbnail: ''
presentation_modality: 'Synchronous Online Presentation'
pronouns: ''
research_mentor: 'Dr. Kyle Hodgen'
research_mentor_s_college: 'FSU PC'
research_mentor_s_department: DNAP
research_mentor_s_email: rkh23a@fsu.edu
student_bio: |-
James Sparks - Born and raised in Paris, TX. James Graduated nursing school in 2021 and went directly into an ICU working through the COVID pandemic. It was in the ICU that James found his passion for critical care, and opened the possibility of pursuing nurse anesthesia.
Garrett Verkaik - Garrett was born and raised in central Florida and also graduated nursing school in 2021. Garrett also went directly into the ICU where he developed a desire for individualized care and critical patients, and thus the pursuit of nurse anesthesia.
student_email: gvv23@fsu.edu
student_photo: '72784'
title: 'Ideal Body Weight Dosing of Dexmedetomidine'
update_url: 'https://pc.fsu.edu/student-research/symposium/research-symposium-program-portal?element_parents=elements/student_photo&ajax_form=1&_wrapper_format=drupal_ajax&token=Fr-UJOs8WLgcB80XuQXghdclvPA2s4E2Y3l4pS9dq6Q'
work: Complete
year: '2026'